bioMérieux and Henry Ford Health host U.S. thought leaders on antimicrobial resistance to accelerate diagnostics-driven stewardship and policy

bioMérieux and Henry Ford Health host U.S. thought leaders on antimicrobial resistance to accelerate diagnostics-driven stewardship and policy News provided by bioMerieux Oct 06, 2025, 17:57 ET Share this article Share to X Share this article Share to X Jennifer Zinn (right), bioMérieux Executive Vice President of Clinical Operations (PRNewsfoto/bioMerieux) Linoj Samuel, Division Head for Clinical Microbiology, Henry Ford Health (PRNewsfoto/bioMerieux) Jacinda Abdul-Mutakabbir (middle), PharmD, MPH, AAHIVP, University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences; Geehan Suleyman (second from left), MD, MLS (ASCP), FIDSA, Medical Director of Infection Prevention and Control and Antimicrobial Stewardship, Henry Ford Health (PRNewsfoto/bioMerieux) Robert J. Tibbetts, Ph.D. D(ABMM), F(CCM), FIDSA, Henry Ford Health (PRNewsfoto/bioMerieux) Amanda Harrington, PhD, D(ABMM), Medical Director, Clinical Microbiology Laboratory, Loyola University Medical Center (PRNewsfoto/bioMerieux)